STATE STREET CORP - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$813,173
+19.7%
183,147
-11.1%
0.00%
Q2 2023$679,625
-75.3%
205,947
-78.7%
0.00%
Q1 2023$2,751,926
-75.8%
965,588
-38.1%
0.00%
Q4 2022$11,362,828
+93.6%
1,560,828
+115.1%
0.00%
Q3 2022$5,869,000
+84.7%
725,517
+11.8%
0.00%
Q2 2022$3,178,000
-80.1%
648,666
-4.0%
0.00%
-100.0%
Q1 2022$15,986,000
+29.5%
675,954
-3.1%
0.00%0.0%
Q4 2021$12,346,000
-3.2%
697,911
+54.3%
0.00%0.0%
Q3 2021$12,760,000
+290.0%
452,312
+44.9%
0.00%
Q2 2021$3,272,000
+9.1%
312,225
+22.7%
0.00%
Q1 2021$2,998,000
+6.9%
254,497
+6.3%
0.00%
Q4 2020$2,804,000
+66.7%
239,449
+12.9%
0.00%
Q3 2020$1,682,000
-55.6%
212,055
+2.4%
0.00%
Q2 2020$3,788,000
+63.3%
207,098
+6.6%
0.00%
Q1 2020$2,319,000
+256.8%
194,262
+397.5%
0.00%
Q4 2019$650,00039,0490.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders